Development of an a MC1R selective companion diagnostic imaging probe
Ended Project Grant Awarded Last action
- Award ID
- R43CA235992
- Recipient
-
Modulation Therapeutics, Inc. UEI FPRRYGJGEHB1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $248,155
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- West Virginia, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $248,155 |
Show all 11
Quick answers
Who received award R43CA235992?
R43CA235992 was awarded to Modulation Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on September 18, 2018.
How much is award R43CA235992 worth?
$248,155 has been obligated on R43CA235992.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award